Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1976 1
1977 1
1979 1
1980 3
1981 1
1982 2
1984 1
1985 1
1986 5
1987 2
1988 4
1989 3
1990 3
1991 5
1992 1
1993 6
1994 12
1995 12
1996 7
1997 11
1998 5
1999 3
2000 4
2001 8
2002 6
2003 5
2004 4
2005 8
2006 7
2007 8
2008 11
2009 31
2010 29
2011 32
2012 22
2013 20
2014 35
2015 31
2016 45
2017 35
2018 56
2019 41
2020 38
2021 42
2022 57
2023 46
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

619 results

Results by year

Filters applied: . Clear all
Page 1
The impact of glucocorticoid use on the outcomes of rheumatoid arthritis in a multicenter ultrasound cohort study.
Nonaka F, Fukui S, Michitsuji T, Endo Y, Nishino A, Shimizu T, Umeda M, Sumiyoshi R, Koga T, Iwamoto N, Origuchi T, Ueki Y, Eiraku N, Suzuki T, Okada A, Matsuoka N, Takaoka H, Hamada H, Tsuru T, Arinobu Y, Hidaka T, Fujikawa K, Yoshitama T, Tada Y, Ohtsubo H, Ishizaki J, Asano T, Maeda T, Kawakami A, Kawashiri SY. Nonaka F, et al. Among authors: iwamoto n. Int J Rheum Dis. 2024 Mar;27(3):e15118. doi: 10.1111/1756-185X.15118. Int J Rheum Dis. 2024. PMID: 38487995 Review.
Unfractionated Heparin Safety in COVID-19: Incidence and Risks of Bleeding Complications in Japan.
Sato L, Iwamoto N, Kakumoto Y, Tsuzuki S, Togano T, Ishikane M, Okumura N, Yamada G, Inada M, Suzuki T, Hojo M, Takasaki J, Sasaki R, Kimura A, Teruya K, Okamoto T, Hayakawa K, Hara H, Iseki K, Ohmagari N. Sato L, et al. Among authors: iwamoto n. J Atheroscler Thromb. 2024 Feb 14. doi: 10.5551/jat.64448. Online ahead of print. J Atheroscler Thromb. 2024. PMID: 38355124 Free article.
Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry-a historical cohort study.
Ichinose K, Sato S, Igawa T, Okamoto M, Takatani A, Endo Y, Tsuji S, Shimizu T, Sumiyoshi R, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Yajima N, Sada KE, Miyawaki Y, Yoshimi R, Shimojima Y, Ohno S, Kajiyama H, Sato S, Fujiwara M, Kawakami A. Ichinose K, et al. Among authors: iwamoto n. Arthritis Res Ther. 2024 Feb 12;26(1):48. doi: 10.1186/s13075-024-03285-x. Arthritis Res Ther. 2024. PMID: 38347556 Free PMC article.
Inhibition of PTPN3 Expressed in Activated Lymphocytes Enhances the Antitumor Effects of Anti-PD-1 Therapy in Head and Neck Cancer, Especially in Hypoxic Environments.
Masuda S, Onishi H, Iwamoto N, Imaizumi A, Koga S, Nagao S, Sakanashi K, Itoyama S, Fujimura A, Komune N, Kogo R, Umebayashi M, Morisaki T, Nakagawa T. Masuda S, et al. Among authors: iwamoto n. J Immunother. 2024 Apr 1;47(3):89-97. doi: 10.1097/CJI.0000000000000503. Epub 2024 Feb 1. J Immunother. 2024. PMID: 38297883
Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma.
Maruki T, Nomoto H, Iwamoto N, Yamamoto K, Kurokawa M, Iwatsuki-Horimoto K, Yamayoshi S, Suzuki Y, Kawaoka Y, Ohmagari N. Maruki T, et al. Among authors: iwamoto n. J Infect Chemother. 2024 Jan 17:S1341-321X(24)00012-6. doi: 10.1016/j.jiac.2024.01.008. Online ahead of print. J Infect Chemother. 2024. PMID: 38242284 Free article.
619 results